Literature DB >> 6628476

Urinary and plasma oxalate during ingestion of pure ascorbic acid: a re-evaluation.

N Fituri, N Allawi, M Bentley, J Costello.   

Abstract

Daily ingestion of 8 g of pure ascorbic acid by 8 normal subjects for 7 days did not, in contrast to previous reports in the literature, significantly alter urinary or plasma oxalate during or after ingestion. When urine with raised ascorbate values was heated at 100 degrees C for 30 min, a significant increase in urinary oxalate concentration was observed. Plasma ascorbate reached a mean value during ingestion of 3.3 mg/100 ml. Urinary citrate excretion significantly decreased during the first 4 days of ascorbic acid ingestion; however, the urinary inhibitory activity of calcium oxalate crystal growth was not significantly altered. Urinary and serum urate as well as urinary calcium and magnesium were unaltered by ingestion of the vitamin supplement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628476     DOI: 10.1159/000474110

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

Review 1.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

2.  Ascorbic acid and kidney stones.

Authors:  A Hoffer
Journal:  Can Med Assoc J       Date:  1985-02-15       Impact factor: 8.262

3.  A case-control study of dietary intake of renal stone patients. I. Preliminary analysis.

Authors:  H M Griffith; B O'Shea; B Keogh; J P Kevany
Journal:  Urol Res       Date:  1986

4.  A case-control study of dietary intake of renal stone patients. II. Urine biochemistry and stone analysis.

Authors:  H M Griffith; B O'Shea; M Maguire; B Koegh; J P Kevany
Journal:  Urol Res       Date:  1986

5.  Hippuric acid as a significant regulator of supersaturation in calcium oxalate lithiasis: the physiological evidence.

Authors:  Stoyanka S Atanassova; Ivan S Gutzow
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.